Ovarian Cancer News and Research

RSS
Commonly known as the "silent killer," ovarian cancer leads to approximately 15,000 deaths each year in the United States, according to the American Cancer Society. Approximately 20,000 new cases are diagnosed each year, with the majority in patients diagnosed with late stage disease where the cancer has spread beyond the ovary. The prognosis is poor in these patients, leading to the high mortality from this disease. A diagnostic test is needed that can provide adequate predictive value to stratify patients with a pelvic mass into high risk of invasive ovarian cancer versus those with low risk, as well as a screening test for the diagnosis of early-stage ovarian cancer, which is essential for improving overall survival in patients. Ovarian cancer has up to a 90% cure rate following surgery and/or chemotherapy if detected in stage 1.
Aravive Biologics gains Fast Track Designation for AVB-S6-500 from U.S. FDA

Aravive Biologics gains Fast Track Designation for AVB-S6-500 from U.S. FDA

Ovarian cancer screening influenced by unconscious bias, study shows

Ovarian cancer screening influenced by unconscious bias, study shows

New model of genetically engineered immune cells may help fight solid tumors

New model of genetically engineered immune cells may help fight solid tumors

Scientists identify mutational signatures in ovarian cancer

Scientists identify mutational signatures in ovarian cancer

Scientists unravel the mystery behind ovarian cancer with high-grade serous carcinoma

Scientists unravel the mystery behind ovarian cancer with high-grade serous carcinoma

Silencing of GULP1 gene expression plays important role in ovarian carcinogenesis

Silencing of GULP1 gene expression plays important role in ovarian carcinogenesis

Researchers discover new mechanism linked to inherited breast, ovarian cancer

Researchers discover new mechanism linked to inherited breast, ovarian cancer

BRAF inhibitors may be effective at treating rare ovarian cancer, study shows

BRAF inhibitors may be effective at treating rare ovarian cancer, study shows

Researchers discover various mechanisms of resistance to cancer therapy

Researchers discover various mechanisms of resistance to cancer therapy

Study uncovers new protein complex that shields broken DNA ends

Study uncovers new protein complex that shields broken DNA ends

New technique measures how well cancer drugs reach their targets

New technique measures how well cancer drugs reach their targets

New approach sheds light on effects of drugs on cancer cells

New approach sheds light on effects of drugs on cancer cells

Study does not find causal association between assisted reproduction and ovarian cancer risk

Study does not find causal association between assisted reproduction and ovarian cancer risk

Mayo researchers determine how DNA repair protein gets to the site of damage

Mayo researchers determine how DNA repair protein gets to the site of damage

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

Modified natural killer cells may be new player in CAR-T immunotherapies

Modified natural killer cells may be new player in CAR-T immunotherapies

Genetic subset of prostate cancer may benefit from combination checkpoint immunotherapy

Genetic subset of prostate cancer may benefit from combination checkpoint immunotherapy

KIYATEC enrolls first patients with solid tumors in clinical study of its EV3D drug response assay

KIYATEC enrolls first patients with solid tumors in clinical study of its EV3D drug response assay

Risks of cancer and mortality found to be lowest in light drinkers

Risks of cancer and mortality found to be lowest in light drinkers

Study finds combined risk of death and developing cancer to be lowest in light drinkers

Study finds combined risk of death and developing cancer to be lowest in light drinkers